2UV-26017-98306

4 vaccinations 5 coded responses 28 check-ins 4 free-text entries 3 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 914 / CA
Registered: 2021-04-14

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Registered dependents

9QN-77758-80521 Child or adolescent in my care · Female · 2022-06-29

CS7-20948-46755 Child or adolescent in my care · Female · 2023-05-08

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-26
Dose 1 — Pfizer-BioNTech
2021-04-14
Registered in v-safe
2021-04-14
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-16
Dose 2 — Pfizer-BioNTech
2021-04-18
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Diarrhea

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-23
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-30
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-21
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-30
Survey response — day 42, dose 2
MedDRA: Inflammation — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Inglammation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-30
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-18
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-15
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-04
Dose 3 — Pfizer-BioNTech
2022-04-18
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-05-11
Call 2 — Left Voicemail
2022-07-05
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-18
Dose 4 — Pfizer-BioNTech
2022-09-19
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2022-09-20
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-21
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-22
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-23
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-24
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-25
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-10-02
Survey response — day 14, dose 4
MedDRA: Respiratory tract congestion — Feeling: Good

Free text: Congestion

MedDRA releases: 2024-11 · check-in free text available
2022-10-09
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-16
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-10-23
Survey response — day 35, dose 4
MedDRA: Muscle strain — Feeling: Fair · Be unable to do your normal daily activities

Free text: Muscle strain

MedDRA releases: 2024-11 · check-in free text available
2022-10-30
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-20
Survey response — 3 months, dose 4
MedDRA: Gestational hypertension, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization

Free text: Postpartum hypertension Cold

MedDRA releases: 2024-11 · check-in free text available
2022-12-20
Report sent to call center — 3 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-12-21
Call 3 — Left Voicemail
2022-12-21
Call 2 — Left Voicemail
2023-03-19
Survey response — 6 months, dose 4
MedDRA: Delivery, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

MedDRA releases: 2024-11
2023-03-19
Report sent to call center — 6 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2023-03-21
Call 1 — Left Voicemail
2023-03-21
Call 1 — Left Voicemail
2023-03-21
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-26	Pfizer-BioNTech
2	2021-04-16	Pfizer-BioNTech
3	2022-01-04	Pfizer-BioNTech	No
4	2022-09-18	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-05-30	Unsuccessful
2022-12-20	Unsuccessful
2023-03-19	Unsuccessful

Free text

Release 8 — day 42, dose 2

2021-05-30

Symptoms: Inglammation

Release 12 — day 14, dose 4

2022-10-02

Symptoms: Congestion

Release 12 — day 35, dose 4

2022-10-23

Symptoms: Muscle strain

Release 12 — 3 months, dose 4

2022-12-20

Symptoms: Postpartum hypertension Cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Delivery	·	·	✓
SD	Gestational hypertension	·	·	✓
SD	Inflammation	✓	✓	✓
SD	Muscle strain	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release